RFP Financial Group’s Biogen BIIB Stock Holding History

RFP Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6	Closed	-$1.39K	–	185
2024 Q2	$1.39K	Sell	6 -4	-40%	-$869	﹤0.01%	765
2024 Q1	$2.16K	Buy	+10	New	+$2.34K	﹤0.01%	662

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RFP Financial Group's BIIB Position: Q3 2024 in Review

RFP Financial Group sold out of Biogen (BIIB) in Q3 2024, closing a stake of 6 shares — an estimated $1.39K sold.

RFP Financial Group first reported a position in BIIB in Q1 2024 and held it in 2 quarters. The position peaked at $2.16K in Q1 2024. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

RFP Financial Group reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
RFP Financial Group sold 6 Biogen shares in Q3 2024, an estimated $1.39K.
RFP Financial Group first reported a position in Biogen in Q1 2024 and held it in 2 quarters.
RFP Financial Group's Biogen position peaked at $2.16K in Q1 2024.
916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.